الفهرس 
Hepatitis C virus
Clinical course of HCV infectionOnly 14 pages are availabe for public view
 |  | from | 181 |  |  |
| | | from | 181 | | |
Abstract
HCV is a serious problem in Egypt, while no vaccine is available right now and the current treatments have many side effects in addition to their high cost. In the present study, chitosan was used as a carrier for the natural antiviral product (EGCG) to enhance its biological properties and to make hepatic cell targeting. In this study.